OTC Labeling Trade Dress Issue Resolved In FDA Technical Amendment
This article was originally published in The Rose Sheet
Executive Summary
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label reform rule published in the Jan. 3 Federal Register.